Clinical Trial Update: CD70-Targeted CAR-T Therapy in CD70-Positive Advanced Solid Tumors [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial of a CD70-targeted CAR-T therapy for CD70-positive advanced solid tumors is currently recruiting, enrolling patients with renal cell ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Thyroid Carcinoma
• Cervical Cancer
• Lung Cancer
• Ovarian Cancer
• Renal Cell Carcinoma
• Thymic Carcinoma

Drugs mentioned

• CD70-targeted CAR-T therapy

Snippet

Sponsor: Chongqing Precision Biotech Co., Ltd | Conditions: Renal Cell Carcinoma (RCC), Lung Cancer | Phase 1 | Status: RECRUITING